NIRS for the Diagnosis and Prevention of Acute Renal Failure
NIRS: a Tool for the Diagnosis and Prevention of Acute Renal Failure in Pediatric Cardiac Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
This prospective study will take place at Hotel Dieu de France hospital in Lebanon. One hundred children undergoing cardiac surgery for congenital heart disease between May 2020 and May 2021 will be included. After obtaining the informed consent of the parents, demographic and surgical information will be collected. Serum creatinine, lactic acid, urinary neutrophil gelatinase-associated lipocalin marker (NGAL), and oxygen (O2) saturation will be measured before the operation. A pediatric NIRS sensor will be placed on the right side below the costo-vertebral angle overlying the right kidney and continuous regional oxygen saturation (rSO2) will be recorded every 5 to 10 minutes throughout the operation until 24 hours after surgery. The children will be divided into 2 groups; 50 each. Grp 1: No clinical intervention was performed based on NIRS values. Grp 2: several maneuvers are performed such as an increase in cardiac output, temperature, hemoglobin to optimize the value of NIRS \> 80%. All patients will receive standard standard care during the study period and continuous infusion of furosemide (0.5-1 mg / kg / 6 hours) within the first 24-48 hours postoperatively will be administered to all patients. Creatinine and lactic acid will be measured immediately postoperatively and then once a day until D2 and D7. The urinary NGAL marker will be dosed immediately postoperatively and then at 2h, 6h, 12h and 24h with hourly monitoring of diuresis and NIRS until 24h postoperatively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2020
CompletedStudy Start
First participant enrolled
September 23, 2020
CompletedFirst Posted
Study publicly available on registry
October 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedOctober 28, 2020
October 1, 2020
10 months
March 16, 2020
October 21, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Impact of low renal NIRS values on renal function in children undergoing cardiac surgery.
Monitoring renal NIRS values during the surgery and until 24 hours in the ICU. All values are recorded. A dosage of creatinine is made upon arrival to the ICU , 24 hours later and one week later. A correlation between NIRS values and creatinine changes will be noticed.
7 days
Improving NIRS values prevent acute kidney injury in children undergoing cardiac surgery.
Optimizing renal NIRS values in children undergoing cardiac surgery. Each drop in NIRS values below 10% of its baseline is treated with transfusion and increasing the flow of CPB. Postoperatively, creatinine dosage is made upon arrival to the ICU, At day 1 and 7.
7 days
Secondary Outcomes (4)
Need for dialysis
7 days
Duration of mechanical ventilation
7 days
Length of stay in intensive care units (ICU)
1 month
Deaths within 30 days postoperative
30 days
Study Arms (2)
Group 1
NIRS values will be recorded during the surgery and until 24 hours postoperatively. No intervention will be done.
Group 2
Several maneuvers will be performed in case the NIRS values are below 50%, such as an increase in cardiac output, temperature, hemoglobin to optimize the NIRS value by up to 80%.
Interventions
Several maneuvers will be performed in case the NIRS values are below 50%, such as an increase in cardiac output, temperature, hemoglobin to optimize the NIRS value by up to 80%.
Eligibility Criteria
All patients aged 16 years and under, with normal renal function who are undergoing cardiac surgery with cardiopulmonary bypass from september 2020 until septembre 2021.
You may qualify if:
- Pediatric patients aged 16 years and under, undergoing cardiac surgery with cardiopulmonary bypass at the hotel Dieu de France Hospital, from September 2020 until September 2021.
- Surgeries to include: Tetralogy of Fallot, Transposition of great Vessels, ventricular septal defect, atrial septal defect and atrioventricular septal defect.
- Normal renal function
- Informed consent written and signed by the child's parents
You may not qualify if:
- The refusal of the patient's parents
- Patients with preoperative AKI
- Identification of renal or urinary anatomical abnormalities
- Premature infants \<35 weeks of gestation
- Children with a known genetic or chromosomal abnormality
- Destination to a uni ventricular repair
- Repeated urinary tract infections before the surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hotel Dieu de France Hospital
Beirut, 166830, Lebanon
Biospecimen
A blood test for the dosage of creatinine and urea.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
AFRIDA GERGESS, M.D.
Hotel Dieu de France Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 16, 2020
First Posted
October 28, 2020
Study Start
September 23, 2020
Primary Completion
August 1, 2021
Study Completion
September 1, 2021
Last Updated
October 28, 2020
Record last verified: 2020-10